Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
Saved in:
| Title: | Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? |
|---|---|
| Authors: | GATLIN, ALLISON (AUTHOR) |
| Source: | Investors Business Daily. 9/17/2024, pN.PAG-N.PAG. 1p. |
| Subjects: | Bausch Health Cos. Inc., Investors, Private equity, Irritable colon, Patent suits, Eye care, Growth stocks |
| Abstract: | Bausch + Lomb, a company known for its eye care products, is reportedly exploring a potential sale. The company's stock surged on the news, with private equity being the most likely buyer according to an analyst. Other companies in the eye care market may face antitrust challenges if they were to acquire Bausch + Lomb. The sale could potentially alleviate concerns about the parent company's debt. [Extracted from the article] |
| Copyright of Investors Business Daily is the property of Investor's Business Daily and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Bausch + Lomb, a company known for its eye care products, is reportedly exploring a potential sale. The company's stock surged on the news, with private equity being the most likely buyer according to an analyst. Other companies in the eye care market may face antitrust challenges if they were to acquire Bausch + Lomb. The sale could potentially alleviate concerns about the parent company's debt. [Extracted from the article] |
|---|---|
| ISSN: | 10612890 |
